Literature DB >> 24754478

Neuropeptide S receptor gene variant and environment: contribution to alcohol use disorders and alcohol consumption.

Kariina Laas1, Andreas Reif, Kirsti Akkermann, Evelyn Kiive, Katharina Domschke, Klaus-Peter Lesch, Toomas Veidebaum, Jaanus Harro.   

Abstract

The functional polymorphism Asn(107) Ile (rs324981, A > T) of the neuropeptide S receptor (NPSR1) gene is involved in the modulation of traits that affect alcohol use. Hence, we have examined whether the NPSR1 A/T polymorphism is associated with alcohol use disorders (AUD) and alcohol use in a population-representative sample. Lifetime AUD were assessed by the MINI psychiatric interview (n = 501) in the older cohort of the longitudinal Estonian Children Personality Behaviour and Health Study at age 25. Alcohol use, environmental adversities and personality were reported by both the younger (original n = 583) and the older cohort (original n = 593) in three study waves. NPSR1 associations with AUD and alcohol use differed by sex. In females, both AUD [odds ratio (OR) = 7.20 (0.94-55.0), P = 0.029] and harmful alcohol use were more prevalent in A-allele carriers. In contrast, in males, AUD was more frequent in T-allele carriers [OR = 2.75 (1.19-6.36), P = 0.017], especially if exposed to adverse environments at age 15 [OR = 10 (1.18-84.51), P = 0.019]. Alcohol use was higher in male T-allele carriers at ages 15 and 18 as well. Similarly to females, however, the risk allele for higher alcohol use for males at age 25 was the A-allele. Many of the effects on alcohol use were explained by genotype effects on measures of personality. In the general population, the NPSR1 Asn(107) Ile polymorphism is associated with AUD and alcohol consumption, dependent on sex, environment and age. The results are in line with the impulsivity and personality regulating role of the NPSR1.
© 2014 Society for the Study of Addiction.

Entities:  

Keywords:  Addiction; NPSR1; alcohol; impulsivity; neuropeptide S; personality

Mesh:

Substances:

Year:  2014        PMID: 24754478     DOI: 10.1111/adb.12149

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  7 in total

1.  Neuropeptide S differently modulates alcohol-related behaviors in alcohol-preferring and non-preferring rats.

Authors:  Nazzareno Cannella; Marsida Kallupi; Hong Wu Li; Serena Stopponi; Carlo Cifani; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  Psychopharmacology (Berl)       Date:  2016-05-28       Impact factor: 4.530

2.  Relationship of Neuropeptide S with Clinical and Metabolic Parameters of Patients during Rehabilitation Therapy for Schizophrenia.

Authors:  Agnieszka Markiewicz-Gospodarek; Renata Markiewicz; Beata Dobrowolska; Ryszard Maciejewski; Bartosz Łoza
Journal:  Brain Sci       Date:  2022-06-11

Review 3.  Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics.

Authors:  Massimo Ubaldi; Nazzareno Cannella; Roberto Ciccocioppo
Journal:  Prog Brain Res       Date:  2015-11-26       Impact factor: 2.453

Review 4.  A Role for Neuropeptide S in Alcohol and Cocaine Seeking.

Authors:  Nazzareno Cannella; Anna Maria Borruto; Michele Petrella; Maria Vittoria Micioni Di Bonaventura; Laura Soverchia; Carlo Cifani; Sara De Carlo; Esi Domi; Massimo Ubaldi
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-27

Review 5.  Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.

Authors:  Pascal Valentin Fischler; Michael Soyka; Erich Seifritz; Jochen Mutschler
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

6.  Impulsivity across substance use categories: Consideration of sex/gender.

Authors:  Elise E DeVito; Andrea H Weinberger; Raina D Pang; Nicole Petersen; Tessa Fagle; Alicia M Allen
Journal:  Curr Behav Neurosci Rep       Date:  2020-07-15

7.  Neuropeptide S-Mediated Modulation of Prepulse Inhibition Depends on Age, Gender, Stimulus-Timing, and Attention.

Authors:  Wei Si; Xiaobin Liu; Hans-Christian Pape; Rainer K Reinscheid
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.